MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/brain/awae345

Медицинская библиотека · Brain : a journal of neurology · 2025

Tau, synapse loss and gliosis progress in an Alzheimer's mouse model after amyloid-β immunotherapy.

Welikovitch Lindsay A, Mate de Gerando Anastasie, Khasnavis Anita, Bhavsar Harshil, Meltzer Jonah C, Buée Luc, Chibnik Lori B, Bussiere Thierry, Hyman Bradley T

СтатьяПеревод пока не подготовлен

Аннотация

Preclinical studies assessing drugs for Alzheimer's disease (AD) are conducted in animal models that usually display only one neuropathological feature of AD, whereas patients present with a complex combination of comorbidities and neuropathologies. Importantly, it is well established that amyloid-β (Aβ) plaque and tau tangle accumulation interact in a phase-dependent manner, making it difficult to predict how targeting one might influence the other, as well as downstream degeneration. We developed a transgenic mouse model, APP/PS1xTau22, with progressive cortical Aβ deposition and hippocampal tau neurofibrillary inclusions, to investigate how both neuropathologies act jointly to bring about neural degeneration, synapse loss and glial phenotypes. We then assessed whether applying murine chimeric aducanumab, an anti-amyloid immunotherapy, could impact the synergistic relationship between amyloid and tau. Drug treatment resulted in a ∼70% reduction in Aβ deposition in hippocampal and cortical areas and produced a robust peri-plaque microglial and astrocytic response. Removing amyloid from the brain did not reverse or slow tau pathology or alter synapse loss. Our findings suggest that, once the interaction between amyloid and tau is set in motion, reducing plaque burden by Aβ immunotherapy may stimulate glial responses, but is insufficient to curb degenerative phenotypes in this model.

Для цитирования: Welikovitch Lindsay A, Mate de Gerando Anastasie, Khasnavis Anita, Bhavsar Harshil, Meltzer Jonah C, Buée Luc, Chibnik Lori B, Bussiere Thierry, Hyman Bradley T. Tau, synapse loss and gliosis progress in an Alzheimer's mouse model after amyloid-β immunotherapy.. Brain : a journal of neurology. 2025. DOI: 10.1093/brain/awae345.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.